SO
STRS Ohio Portfolio holdings
AUM
$26.8B
1-Year Return
24.25%
This Quarter Return
+9.29%
1 Year Return
+24.25%
3 Year Return
+105.97%
5 Year Return
+185.64%
10 Year Return
+428.63%
AUM
$27.8B
AUM Growth
+$1.24B
(+4.7%)
Cap. Flow
-$916M
Cap. Flow
% of AUM
-3.29%
Top 10 Holdings %
Top 10 Hldgs %
21.54%
Holding
2,539
New
369
Increased
763
Reduced
883
Closed
319
Top Buys
| 1 |
Snap
SNAP
|
+$39.3M |
| 2 |
Yeti Holdings
YETI
|
+$36.3M |
| 3 |
LSI
Life Storage, Inc.
LSI
|
+$35.3M |
| 4 |
Cboe Global Markets
CBOE
|
+$34.5M |
| 5 |
Moderna
MRNA
|
+$34.3M |
Top Sells
| 1 |
Apple
AAPL
|
+$78.6M |
| 2 |
Linde
LIN
|
+$64.8M |
| 3 |
UnitedHealth
UNH
|
+$58.3M |
| 4 |
First Horizon
FHN
|
+$48.9M |
| 5 |
Parker-Hannifin
PH
|
+$45.9M |
Sector Composition
| 1 | Technology | 23.72% |
| 2 | Financials | 16.15% |
| 3 | Healthcare | 11.99% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
ServisFirst Bancshares
SFBS
$4.6B
| $88K | ﹤0.01% |
+1,300
| New | +$88K |
|
2002
United Natural Foods
UNFI
$1.72B
| $88K | ﹤0.01% |
2,400
| – | – |
|
2003
Forte Biosciences
FBRX
$135M
| $87K | ﹤0.01% |
+104
| New | +$87K |
|
2004
Impinj
PI
$5.53B
| $87K | ﹤0.01% |
+1,700
| New | +$87K |
|
2005
Pliant Therapeutics
PLRX
$104M
| $87K | ﹤0.01% |
3,000
+400
| +15% | +$11.6K |
|
2006
JFrog
FROG
$5.8B
| $86K | ﹤0.01% |
+1,900
| New | +$86K |
|
2007
Tradeweb Markets
TW
$25.3B
| $86K | ﹤0.01% |
1,020
| – | – |
|
2008
Forestar Group
FOR
$1.4B
| $85K | ﹤0.01% |
4,100
| – | – |
|
2009
SEI Investments
SEIC
$10.7B
| $85K | ﹤0.01% |
1,381
-468,000
| -100% | -$28.8M |
|
2010
Zillow
ZG
$20B
| $85K | ﹤0.01% |
699
-5,525
| -89% | -$672K |
|
2011
Ardelyx
ARDX
$1.6B
| $84K | ﹤0.01% |
11,120
| – | – |
|
2012
Keros Therapeutics
KROS
$636M
| $84K | ﹤0.01% |
2,000
+200
| +11% | +$8.4K |
|
2013
Tonix Pharmaceuticals
TNXP
$237M
| – | – |
0
| – | – |
|
2014
Zevra Therapeutics
ZVRA
$448M
| $84K | ﹤0.01% |
+6,600
| New | +$84K |
|
2015
ClearPoint Neuro
CLPT
$299M
| $83K | ﹤0.01% |
+4,400
| New | +$83K |
|
2016
Ouster
OUST
$1.64B
| $83K | ﹤0.01% |
+670
| New | +$83K |
|
2017
Amphastar Pharmaceuticals
AMPH
$1.32B
| $82K | ﹤0.01% |
+4,100
| New | +$82K |
|
2018
Cullinan Oncology
CGEM
$382M
| $82K | ﹤0.01% |
3,200
| – | – |
|
2019
Oramed Pharmaceuticals
ORMP
$95.5M
| $82K | ﹤0.01% |
+6,200
| New | +$82K |
|
|
JNCE
2020
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $82K | ﹤0.01% |
12,200
| – | – |
|
2021
CuriosityStream
CURI
$258M
| $81K | ﹤0.01% |
+6,000
| New | +$81K |
|
2022
AgEagle Aerial Systems
UAVS
$69.8M
| $81K | ﹤0.01% |
+16
| New | +$81K |
|
2023
Inotiv
NOTV
$47.8M
| $80K | ﹤0.01% |
+3,000
| New | +$80K |
|
2024
SiriusXM
SIRI
$8.02B
| $80K | ﹤0.01% |
1,235
-3,890
| -76% | -$252K |
|
2025
GCM Grosvenor
GCMG
$681M
| $79K | ﹤0.01% |
+7,600
| New | +$79K |
|